O, K., LM, M., AI, S., MK, H., P, L., BA, O., . . . KL, K. (2024). Exopolysaccharide-Treated Dendritic Cells Effectively Ameliorate Acute Graft-versus-Host Disease. Transplantation and cellular therapy, 30(1), 79.e1-79.e10. https://doi.org/10.1016/j.jtct.2023.10.023
Chicago Style (17th ed.) CitationO, Kalinina, Minter LM, Sperling AI, Hollinger MK, Le P, Osborne BA, Zhang S, Stiff P, and Knight KL. "Exopolysaccharide-Treated Dendritic Cells Effectively Ameliorate Acute Graft-versus-Host Disease." Transplantation and Cellular Therapy 30, no. 1 (2024): 79.e1-79.e10. https://doi.org/10.1016/j.jtct.2023.10.023.
MLA (9th ed.) CitationO, Kalinina, et al. "Exopolysaccharide-Treated Dendritic Cells Effectively Ameliorate Acute Graft-versus-Host Disease." Transplantation and Cellular Therapy, vol. 30, no. 1, 2024, pp. 79.e1-79.e10, https://doi.org/10.1016/j.jtct.2023.10.023.